Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages

Tumor necrosis factor α (TNFα) drives the pathophysiology of human autoimmune diseases and consequently, neutralizing antibodies (Abs) or Ab-derived molecules directed against TNFα are essential therapeutics. As treatment with several TNFα blockers has been reported to entail a higher risk of infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Arens, Katharina, Filippis, Christodoulos, Kleinfelder, Helen, Goetzee, Arthur, Reichmann, Gabriele, Crauwels, Peter, Waibler, Zoe, Bagola, Katrin, van Zandbergen, Ger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079256/
https://www.ncbi.nlm.nih.gov/pubmed/30108591
http://dx.doi.org/10.3389/fimmu.2018.01772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079256/
https://www.ncbi.nlm.nih.gov/pubmed/30108591
http://dx.doi.org/10.3389/fimmu.2018.01772

Ejemplares similares